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Background
Anal cancer in the general population is more prevalent
in women, but in most HIV populations, MSM have the
highest risk. Data suggest that screening can prevent
invasive carcinoma. Use of routine cervical pap smears
resulted in an 80% reduction in cervical cancer rates.
The current study examines the effectiveness of a clini-
cal intervention designed to increase anal dysplasia
education, screening, and treatment for HIV+ MSM.
Methods
To assess anal dysplasia knowledge, sexual history/beha-
vior, and attitudes about health care, a convenience
sample of HIV+ MSM (≥18 years, English-speaking)
being seen for routine care were asked to complete a
questionnaire. The questionnaire assessed anal dysplasia
knowledge and acceptance of screening anal pap utiliz-
ing a 5-point Likert-scale. Subjects were categorized as
having anal dysplasia knowledge and accepting of anal
pap smear if they answered “agree” or “strongly agree.”
A chi-square analysis was conducted to determine
whether those with anal dysplasia knowledge signifi-
cantly differed from those who did not in terms of anal
pap screening. Clinical information was abstracted from
medical records.
Results
Of 142 subjects, 56% were Caucasian, 39% were African
American, and 5% were of other ethnicities with a mean
age of 44 years (SD 10.74 years) and eighth grade or
higher reading level (88%). Most (92%) subjects were on
ART with median HIV RNA <48 copies per mL and
median CD4 534 cells/UL. Although less than half
(39%) of the participants felt their current knowledge of
anal dysplasia was sufficient to make decisions about
detection and treatment, acceptance of anal pap smear
screening was close to universal (93%). One-third of
subjects (50) had undergone anal pap testing and of
these, 44% had dysplasia. Knowledge of dysplasia was
not significantly correlated with anal pap screening
(p=.37).
Conclusions
We found a high acceptance rate of anal pap smear
despite low rates of knowledge about anal dysplasia.
Importantly, anal dysplasia knowledge did not differ
between patients who had been previously screened for
anal dysplasia and those who had not. These results
suggest that the clinical intervention to increase anal
dysplasia screening and treatment must also focus on
patient education and awareness. The high acceptance
rate of the anal pap test indicates that, if implemented
effectively, anal dysplasia screening should be well
received by patients.
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